Bioniche Life Sciences Inc., of Belleville, Ontario, said it filed a preliminary short form prospectus with securities regulatory authorities in each of the provinces in Canada, excluding Quebec, in connection with an overnight marketed offering with Dundee Securities Ltd. acting as the sole agent. The offering will consist of units, with the price per unit to be determined in the context of the market.